Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.19.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.100EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.43.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.407EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.423EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.281EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.230EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.535EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.564.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.345EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.450EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.334EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.589EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.335EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.169EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.442EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.75EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.106EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
D.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.593EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.438.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.38.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.76EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.6.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used